Affluent Medical

Report Publication Announcement • Jan 24, 2022

2022 financial communication calendar

Affluent Medical (ISIN code: FR0013333077 – mnemonic: AFME), a French medtech specialised in the international development and industrialisation of innovative medical prostheses – at a clinical stage – to treat urinary incontinence and the pathology of the heart mitral valve, today is announcing its 2022 financial communication calendar.

• Tuesday, March 29, 2022 Publication of financial statements as of December 31, 2021
• Thursday, September 22, 2022 Publication of financial statements as of June 30, 2022

All communications are published after market close. This schedule is provided for information purposes only and may change.

About Affluent Medical

Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the preclinical and clinical study phase. The first medical device should be marketed in Europe with Kalios. For more information, please visit: www.affluentmedical.com

Contacts:

jjullia@actifin.fr

AFFLUENT MEDICAL Jérôme Geoffroy Chief Financial Officer investor@affluentmedical.com

ACTIFIN, financial press relations Jennifer Jullia +33 (0)6 47 97 54 87

ACTIFIN, financial communication Ghislaine Gasparetto +33 (0)6 21 10 49 24 affluentmedical@actifin.fr

DGM, corporate press relations

Thomas Roborel de Climens +33 (0)6 14 50 15 84 thomasdeclimens@dgm-conseil.fr